“Modular” IDE Proposal Aims To Reduce IRB Review Delays
This article was originally published in The Gray Sheet
Executive Summary
A modular submission process for investigational device exemptions could allow firms to get clinical trials off the ground more quickly, according to Guidant Director of Compliance and Regulatory Affairs Nicholas Horvath